FDA approves GSK & Spero Therapeutics' Tebipenem HBr?

As of market creation, the FDA's expected decision date for the specified application is June 18, 2026. This market will resolve to "Yes" if the U.S. Food and Drug Administration (FDA) grants full or conditional approval for GSK & Spero Th…